MENU
+Compare
VOR
Stock ticker: NASDAQ
AS OF
Jun 6 closing price
Price
$0.22
Change
-$0.00 (-0.00%)
Capitalization
27.97M

VOR Vor Biopharma Forecast, Technical & Fundamental Analysis

Vor Biopharma Inc is a clinical stage cell therapy company... Show more

VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VOR with price predictions
May 28, 2025

VOR in upward trend: price expected to rise as it breaks its lower Bollinger Band on May 05, 2025

VOR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 33 cases where VOR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on May 22, 2025. You may want to consider a long position or call options on VOR as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VOR just turned positive on May 27, 2025. Looking at past instances where VOR's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VOR advanced for three days, in of 180 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VOR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.423) is normal, around the industry mean (16.080). P/E Ratio (0.000) is within average values for comparable stocks, (59.383). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.197). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (268.270).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VOR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VOR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VOR is expected to report earnings to fall 23.08% to -20 cents per share on August 07

Vor Biopharma VOR Stock Earnings Reports
Q2'25
Est.
$-0.20
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.10
Q3'24
Est.
$-0.40
Q2'24
Beat
by $0.01
The last earnings report on May 29 showed earnings per share of -25 cents, missing the estimate of -25 cents. With 609.88K shares outstanding, the current market capitalization sits at 27.97M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Cambridgepark Drive
Phone
+1 617 655-6580
Employees
168
Web
https://www.vorbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

VOR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VOR has been loosely correlated with VXRT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if VOR jumps, then VXRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VOR
1D Price
Change %
VOR100%
+2.31%
VXRT - VOR
36%
Loosely correlated
-2.36%
QSI - VOR
36%
Loosely correlated
-7.29%
CDIO - VOR
36%
Loosely correlated
+1.41%
CVAC - VOR
35%
Loosely correlated
+2.07%
NCNA - VOR
34%
Loosely correlated
-3.85%
More